Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Herantis Pharma Oyj : Managers' Transactions – Sigrid Booms

Herantis Pharma Plc Company release 23 Apr 2021 at 2:00pm EETHerantis Pharma Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Booms, Sigrid Position: Other senior manager Issuer: Herantis Pharma Plc LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20210422163425_2 ____________________________________________ Transaction date: 2021-04-21 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Herantis Pharma Oyj : Managers' Transactions – Henri Huttunen

Herantis Pharma Plc Company release 23 Apr 2021 at 2:00pm EETHerantis Pharma Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Huttunen, Henri Position: Other senior manager Issuer: Herantis Pharma Plc LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20210422224350_2 ____________________________________________ Transaction date: 2021-04-21 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Herantis Pharma Oyj : Managers' Transactions – Tone Kvåle

Herantis Pharma Plc Company release 23 Apr 2021 at 2:00pm EETHerantis Pharma Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Kvåle, Tone Position: Chief Financial Officer Issuer: Herantis Pharma Plc LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20210422162849_2 ____________________________________________ Transaction date: 2021-04-21 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Herantis Pharma Oyj : Managers' Transactions – Magnus Sjögren

Herantis Pharma Plc Company release 23 Apr 2021 at 2:00pm EETHerantis Pharma Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Sjögren, Magnus Position: Other senior manager Issuer: Herantis Pharma Plc LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20210422224930_2 ____________________________________________ Transaction date: 2021-04-21 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Herantis Pharma Oyj : Managers' Transactions – Antti Vuolanto

Herantis Pharma Plc Company release 23 Apr 2021 at 2:00pm EETHerantis Pharma Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: Vuolanto, Antti Position: Other senior manager Issuer: Herantis Pharma Plc LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20210422160620_2 ____________________________________________ Transaction date: 2021-04-21 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Skanska builds substation at Kollsnes, Norway, for NOK 390M, about SEK 380M

Skanska has signed a contract with the energy company Equinor on the construction of a substation at Kollsnes, Norway. The contract is worth NOK 390M, about SEK 380M, and will be included in the Nordic order bookings for the second quarter 2021.The contract is a part of the Troll West electrification project that includes partial electrification of the Troll B platform and full electrification of Troll C in the North Sea. This means that both platforms’ power demand will be met from shore. The project will help cut emissions on the Norwegian continental shelf substantially. In addition

Resolutions at Lifco's AGM 2021

Today, Friday 23 April 2021, the Annual General Meeting of Lifco  AB was held. Due to the ongoing pandemic, the Meeting was held digitally through electronic connection and with opportunity for shareholders to also vote by post. The following main resolutions were made: Dividend In accordance with the proposal of the Board of Directors and the CEO, the Meeting resolved to declare a dividend of SEK 6.00 per share. 27 April 2021 was determined as record date for dividend. Election of Board of Directors Carl Bennet, Ulrika Dellby, Annika Espander, Dan Frohm,

The Patent and Market Court of Appeal issues judgement confirming C-RAD's entitlement to Beamocular's invention

The Patent and Market Court of Appeal at the Svea Court of Appeal partly confirms the judgment of the Patent and Market Court of 26 July 2019, which gave C-RAD the right to the invention described in the patent application entitled “Ionizing radiation detecting device”. The judgment from the Patent and Market Court of Appeal gives C-RAD the right to 50 percent of the invention as certain minor parts of the invention origins from Beomocular, a company in bankruptcy. C-RAD sued Beamocular in May 2017. The judgment of the Patent and Market Court of Appeal cannot be appealed. Both parties will

Klarna partners with Milkywire for their sustainability initiative Give One

Klarna has launched its global Giveone.com platform and commitment to sustainability in time for Earth Day. News Summary: · Klarna is partnering with Milkywire to commit 1% of all funding rounds to planet health initiatives. · With Milkywire as their main impact partner, Klarna will initiate the partnership through a $10 million USD donation dedicated to projects working to solve the climate and biodiversity crisis. STOCKHOLM, April 22, 2021 – Klarna, the fintech frontrunner, has chosen Milkywire, a new digital platform for enabling impact through grassroots NGOs, as their

Financial Report January – March 2021

Stockholm, Sweden, April 23, 2021(NYSE: ALV and SSE: ALIV.sdb)Q1 2021: Good progress in sales, profits, balance sheet Financial highlights Q1 2021 $2,242m net sales17.9% organic sales growth*10.6% operating margin10.6% adjusted operating margin*$1.79 EPS - an increase of 108%$1.79 adjusted EPS* - an increase of 103% Full year 2021 indicationsAround 23% net sales growthAround 20% organic sales growthAround 10% adjusted operating margin  Key business developments in the first quarter of 2021 · Strong organic sales growth*, fueled by good performance in all

Complement - Bluestep Bank’s Annual General Meeting 2021 and Annual and Sustainability report 2020

The complement refers to the attachment of the Annual and Sustainability report 2020 in its entirety and updated contact details. Bluestep Bank AB (publ)’s Annual General Meeting (AGM) was concluded on the 22nd of April 2021. The AGM decided to re-elect the Board of Directors and auditor. The Board of Directors and the Chief Executive Officer also present the Annual report of Bluestep Bank AB (publ) for 2020.Among other things, the AGM resolved the following: · The AGM approved the accounts for Bluestep Bank as well as the consolidated income statement and balance sheet. · The

Fellow Finance expands the product offer in the Polish market

FELLOW FINANCE PLC PRESS RELEASE 23.4.2021 AT 12:30 PMFellow Finance expands the product offer in the Polish market. In addition to the currently available consumer loans, Fellow Finance rolls out its business finance service for small and medium-sized enterprises (SMEs). Now Polish companies will have an opportunity to fund their invoices easily and conveniently through Fellow Finance platform. This will help businesses to increase the financial liquidity and release the working capital. “After a successful implementation of business lending products together with promising volume

Invitation to Qlife Q1 2021 report presentation May 5, 2021

Qlife will publish its Q1 report for 2021 on May 5, at 08:00 CET. A presentation of the report will be held the same day at 10:30 CET via audiocast.Qlife invites investors, financial analysts and the media to a presentation where Thowas Warthoe will comment on the report. The report will be released at 08:00 and will be available at https://qlifeholding.com/sv/investerare/finansiella-rapporter The presentation will be held in English at 10:30 CET and will be followed by a Q&A session. To participate at the presentationIf you wish to participate via teleconference, please click on

AAK’s Interim report for the first quarter 2021 – continued earnings growth in a time of volatility and uncertainty

AAK Group · Total volumes for the quarter were on par with last year and amounted to 569,000 MT (569,000). · Operating profit, including a negative currency translation impact of SEK 57 million, increased by 2 percent, reaching SEK 551 million (542). · Profit for the period amounted to SEK 400 million (383), an increase by 4 percent. · Earnings per share increased by 4 percent, to SEK 1.56 (1.50). · Cash flow from operating activities amounted to SEK 58 million (71). · Return on Capital Employed (ROCE), R12M, was 14.4 percent (14.3 at December 31, 2020). Business

Annual general meeting held in GomSpace Group AB (publ)

Today, the annual general meeting of 2021 has been held in GomSpace Group AB (publ) (the “Company” or “GomSpace”). Below follows a summary of the decisions taken by the annual general meeting (all in accordance with the proposals presented in the notice to attend the meeting kept available at the Company’s website gomspace.com). The annual general meeting resolved: · to adopt the profit and loss statement and the balance sheet and the group profit and loss statement and the group balance sheet for the financial year 2020; · that the Company’s accumulated profits shall be carried

Stockmann’s Interim report for January–March 2021 will be published as an Interim Management Statement

STOCKMANN plc, Other information disclosed according to the rules of the Exchange 23.4.2021 at 12:00 EETStockmann plc will publish its Interim report for January–March 2021 as a shorter Interim Management Statement. The publishing date and time will remain the same, 30 April 2021 at 8:00.The press and analyst briefing will be held on 30 April 2021 at 10:00 as a live webcast, that can be followed by this link  or on the address stockmanngroup.com.  The recording and presentation material are

Sensor Alarm Norden’s first day of trading

Today is the first trading day in Sensor Alarm Norden AB who is active in the security industry and offers a wide range of security solutions for villas, apartments, garages, and commercial properties.Their offering consists of alarms connected to mobile devices that are rented out on a subscription basis. In addition to the main activities, security guards and alarm networks are offered for neighborhood cooperation. The largest business is found in the Nordic market.     Sensor Alarm Norden's new share issue was subscribed to approximately 279 percent of the offer, and the

Resolutions at Swedish Stirling’s Annual General Meeting 2021

At the Annual General Meeting (the “AGM”) of Swedish Stirling AB (publ) on 23 April 2021, which was held through postal voting without physical presence in accordance with temporary legislation, the following was resolved.Election of Board of DirectorsSven Sahle, Andreas Ahlström, Carina Andersson, Gunilla Spongh and Erik Wigertz were re-elected as members of the Board. Sven Sahle was re-elected as Chairman of the Board and Gunilla Spongh was elected as new deputy Chairman of the Board. Board remunerationThe AGM resolved that Board remuneration shall be paid by SEK 200,000 and SEK

Invitation to presentation of LeoVegas first quarter 2021

LeoVegas interim report for the first quarter 2021 will be published at 08:00 CET on May 6, 2021. A webcast telephone conference will be held at 09:00 CET the same day, where Gustaf Hagman, CEO, and Stefan Nelson, CFO, will present the results. A possibility will be given to ask questions via the webcast and follow the presentation live. The webcast will be accessible at: · https://edge.media-server.com/mmc/p/x6q2utt4 To participate in the conference call by phone, please call one of the following numbers: · SE: +46 (0) 8 50 69 21 80 · UK: +44 (0) 20 71 92 80 00 · US:

Mercell Holding - Conversion to a public limited liability company completed and new name and board of directors registered

Oslo, 23 April 2021: Reference is made to the stock exchange announcement by Mercell Holding AS (the "Company") on 22 April 2021, regarding the annual general meeting of the Company held on the same day. The general meeting inter alia resolved to convert the Company from a private limited liability company to a public limited liability company, and thereby changes its legal name to Mercell Holding ASA, and changes the board of directors. The resolutions of the annual general meeting were registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret) today, on 23

SRV to build Laakso Joint Hospital in Helsinki

SRV GROUP PLC    INSIDE INFORMATION       23 APRIL 2021     11:00 EET SRV to build Laakso Joint Hospital in Helsinki SRV has been chosen to develop and build Laakso Joint Hospital in Helsinki as an alliance project. The clients are the City of Helsinki and the Helsinki and Uusimaa Hospital District. The project is divided into several development and construction phases, with a total value of approximately EUR 730 million. The project will be entered in SRV's order backlog in accordance with the ordered phases during the years 2021-2028. The project will not tie up SRV's capital and,

Invitation to Q1 2021 webcast

Zalaris ASA will release its first quarter 2021 results on Thursday 29 April 2021.Zalaris will host a webcast for all shareholders and interested parties on 29 April at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com. Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

BioStock: First approved patent in the US for Iconovo's ICOone

ICOone is Iconovo's single-dose inhaler for simple and cost-effective administration of vaccines and biomolecules. The first US patent has now been approved for the inhaler and thus the company has approved patents for ICOone in Sweden, Europe (EPO), India, and the USA. The patents for ICOone provide, among other things, strong protection for the Covid-19 vaccination opportunities that Iconovo is exploring together with ISR Immune System Regulation.Read the full article at biostock.se:https://www.biostock.se/en/first-approved-patent-in-the-us-for-iconovos-icoone/ This is a press

There are no items matching the current filter
There are no more items matching the current filter
Back to top